TrialBritish journal of clinical pharmacology2007

The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.

Jean Lefebvre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.